nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—CHRM3—epilepsy syndrome	0.204	0.371	CbGaD
Diphenidol—CHRM1—epilepsy syndrome	0.19	0.346	CbGaD
Diphenidol—CHRM2—epilepsy syndrome	0.156	0.283	CbGaD
Diphenidol—Doxapram—Fosphenytoin—epilepsy syndrome	0.114	0.301	CrCrCtD
Diphenidol—Doxapram—Phenytoin—epilepsy syndrome	0.0782	0.207	CrCrCtD
Diphenidol—Antazoline—Phenytoin—epilepsy syndrome	0.0566	0.149	CrCrCtD
Diphenidol—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0425	0.112	CrCrCtD
Diphenidol—Benzphetamine—Phenytoin—epilepsy syndrome	0.0314	0.083	CrCrCtD
Diphenidol—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0291	0.0769	CrCrCtD
Diphenidol—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0269	0.071	CrCrCtD
Diphenidol—Doxapram—KCNK9—epilepsy syndrome	0.000434	0.0718	CrCbGaD
Diphenidol—Doxapram—KCNK3—epilepsy syndrome	0.000434	0.0718	CrCbGaD
Diphenidol—Biperiden—CHRNA2—epilepsy syndrome	0.000281	0.0464	CrCbGaD
Diphenidol—Cycrimine—CHRM1—epilepsy syndrome	0.000199	0.0329	CrCbGaD
Diphenidol—Bepridil—CACNA2D2—epilepsy syndrome	0.000182	0.0301	CrCbGaD
Diphenidol—Bepridil—CACNA1A—epilepsy syndrome	0.000173	0.0286	CrCbGaD
Diphenidol—Difenoxin—OPRM1—epilepsy syndrome	0.000156	0.0259	CrCbGaD
Diphenidol—Loperamide—CACNA1A—epilepsy syndrome	0.000153	0.0253	CrCbGaD
Diphenidol—Diphenoxylate—OPRD1—epilepsy syndrome	0.000144	0.0238	CrCbGaD
Diphenidol—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000128	0.0211	CrCbGaD
Diphenidol—Biperiden—CHRM1—epilepsy syndrome	0.000123	0.0203	CrCbGaD
Diphenidol—Procyclidine—CHRM3—epilepsy syndrome	0.000122	0.0203	CrCbGaD
Diphenidol—Clidinium—CHRM3—epilepsy syndrome	0.000117	0.0194	CrCbGaD
Diphenidol—Procyclidine—CHRM1—epilepsy syndrome	0.000114	0.0189	CrCbGaD
Diphenidol—Trospium—CHRM3—epilepsy syndrome	0.000113	0.0187	CrCbGaD
Diphenidol—Fexofenadine—SLCO1A2—epilepsy syndrome	0.000113	0.0187	CrCbGaD
Diphenidol—Trihexyphenidyl—CHRM3—epilepsy syndrome	0.000112	0.0185	CrCbGaD
Diphenidol—Diphenoxylate—OPRM1—epilepsy syndrome	0.00011	0.0182	CrCbGaD
Diphenidol—Clidinium—CHRM1—epilepsy syndrome	0.00011	0.0181	CrCbGaD
Diphenidol—Bepridil—CACNA1H—epilepsy syndrome	0.000108	0.0178	CrCbGaD
Diphenidol—Loperamide—POMC—epilepsy syndrome	0.000106	0.0175	CrCbGaD
Diphenidol—Trospium—CHRM1—epilepsy syndrome	0.000105	0.0174	CrCbGaD
Diphenidol—Trihexyphenidyl—CHRM1—epilepsy syndrome	0.000104	0.0173	CrCbGaD
Diphenidol—Bepridil—CACNA1D—epilepsy syndrome	0.000102	0.0168	CrCbGaD
Diphenidol—Biperiden—CHRM2—epilepsy syndrome	0.0001	0.0166	CrCbGaD
Diphenidol—Isopropamide—CHRM3—epilepsy syndrome	9.98e-05	0.0165	CrCbGaD
Diphenidol—Mepenzolate—CHRM3—epilepsy syndrome	9.44e-05	0.0156	CrCbGaD
Diphenidol—Procyclidine—CHRM2—epilepsy syndrome	9.33e-05	0.0154	CrCbGaD
Diphenidol—Flavoxate—CHRM1—epilepsy syndrome	9.31e-05	0.0154	CrCbGaD
Diphenidol—Isopropamide—CHRM1—epilepsy syndrome	9.31e-05	0.0154	CrCbGaD
Diphenidol—Mepenzolate—CHRM1—epilepsy syndrome	8.81e-05	0.0146	CrCbGaD
Diphenidol—Trospium—CHRM2—epilepsy syndrome	8.61e-05	0.0142	CrCbGaD
Diphenidol—Trihexyphenidyl—CHRM2—epilepsy syndrome	8.53e-05	0.0141	CrCbGaD
Diphenidol—Darifenacin—CHRM3—epilepsy syndrome	8.21e-05	0.0136	CrCbGaD
Diphenidol—Darifenacin—CHRM1—epilepsy syndrome	7.65e-05	0.0127	CrCbGaD
Diphenidol—Flavoxate—CHRM2—epilepsy syndrome	7.6e-05	0.0126	CrCbGaD
Diphenidol—Clotrimazole—CYP11A1—epilepsy syndrome	7.59e-05	0.0126	CrCbGaD
Diphenidol—Mepenzolate—CHRM2—epilepsy syndrome	7.19e-05	0.0119	CrCbGaD
Diphenidol—Dextropropoxyphene—OPRD1—epilepsy syndrome	6.27e-05	0.0104	CrCbGaD
Diphenidol—Darifenacin—CHRM2—epilepsy syndrome	6.25e-05	0.0103	CrCbGaD
Diphenidol—Fentanyl—OPRD1—epilepsy syndrome	6.2e-05	0.0103	CrCbGaD
Diphenidol—Loperamide—OPRD1—epilepsy syndrome	5.97e-05	0.00988	CrCbGaD
Diphenidol—Levomethadyl Acetate—OPRM1—epilepsy syndrome	5.55e-05	0.00918	CrCbGaD
Diphenidol—Dextropropoxyphene—OPRM1—epilepsy syndrome	4.8e-05	0.00794	CrCbGaD
Diphenidol—Fentanyl—OPRM1—epilepsy syndrome	4.75e-05	0.00785	CrCbGaD
Diphenidol—Biperiden—CYP2D6—epilepsy syndrome	4.59e-05	0.00759	CrCbGaD
Diphenidol—Loperamide—OPRM1—epilepsy syndrome	4.57e-05	0.00756	CrCbGaD
Diphenidol—Methadone—OPRD1—epilepsy syndrome	4.25e-05	0.00703	CrCbGaD
Diphenidol—Clotrimazole—ABCC2—epilepsy syndrome	4.17e-05	0.0069	CrCbGaD
Diphenidol—Trospium—CYP2D6—epilepsy syndrome	3.94e-05	0.00651	CrCbGaD
Diphenidol—Biperiden—ABCB1—epilepsy syndrome	3.28e-05	0.00542	CrCbGaD
Diphenidol—Methadone—OPRM1—epilepsy syndrome	3.25e-05	0.00538	CrCbGaD
Diphenidol—Benzphetamine—ADRA2A—epilepsy syndrome	3.04e-05	0.00503	CrCbGaD
Diphenidol—Clotrimazole—CYP2C19—epilepsy syndrome	2.9e-05	0.0048	CrCbGaD
Diphenidol—Darifenacin—CYP2D6—epilepsy syndrome	2.86e-05	0.00473	CrCbGaD
Diphenidol—Fexofenadine—CYP2D6—epilepsy syndrome	2.78e-05	0.0046	CrCbGaD
Diphenidol—Clotrimazole—CYP2D6—epilepsy syndrome	2.15e-05	0.00356	CrCbGaD
Diphenidol—Bepridil—CYP2D6—epilepsy syndrome	2e-05	0.00331	CrCbGaD
Diphenidol—Fexofenadine—ABCB1—epilepsy syndrome	1.99e-05	0.00329	CrCbGaD
Diphenidol—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.86e-05	0.00307	CrCbGaD
Diphenidol—Loperamide—CYP2D6—epilepsy syndrome	1.77e-05	0.00293	CrCbGaD
Diphenidol—Methadone—CYP2C19—epilepsy syndrome	1.7e-05	0.00281	CrCbGaD
Diphenidol—Clotrimazole—ABCB1—epilepsy syndrome	1.53e-05	0.00254	CrCbGaD
Diphenidol—Bepridil—ABCB1—epilepsy syndrome	1.43e-05	0.00236	CrCbGaD
Diphenidol—Fentanyl—ABCB1—epilepsy syndrome	1.31e-05	0.00217	CrCbGaD
Diphenidol—Loperamide—ABCB1—epilepsy syndrome	1.26e-05	0.00209	CrCbGaD
Diphenidol—Methadone—CYP2D6—epilepsy syndrome	1.26e-05	0.00208	CrCbGaD
Diphenidol—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.25e-05	0.000193	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.24e-05	0.000192	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.23e-05	0.00019	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.23e-05	0.00019	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.22e-05	0.000188	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.22e-05	0.000188	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.21e-05	0.000187	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.21e-05	0.000186	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.19e-05	0.000184	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.19e-05	0.000184	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.18e-05	0.000182	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.18e-05	0.000182	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.18e-05	0.000181	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.17e-05	0.000181	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.17e-05	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.16e-05	0.000179	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.14e-05	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.14e-05	0.000176	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.13e-05	0.000174	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.13e-05	0.000174	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.12e-05	0.000173	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.11e-05	0.000172	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.11e-05	0.000171	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.11e-05	0.000171	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.1e-05	0.000169	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.09e-05	0.000168	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.07e-05	0.000165	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.07e-05	0.000165	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.06e-05	0.000163	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.05e-05	0.000162	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.05e-05	0.000162	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.04e-05	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.04e-05	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.03e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.03e-05	0.00016	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.02e-05	0.000158	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.02e-05	0.000158	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.02e-05	0.000157	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.02e-05	0.000157	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.01e-05	0.000156	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.01e-05	0.000156	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	9.94e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	9.91e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	9.88e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	9.86e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	9.86e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	9.86e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	9.86e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	9.86e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	9.82e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	9.82e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	9.82e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	9.82e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	9.82e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	9.81e-06	0.000151	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PLCB1—epilepsy syndrome	9.77e-06	0.000151	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—TH—epilepsy syndrome	9.74e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	9.73e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	9.73e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	9.73e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	9.73e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	9.73e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	9.72e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	9.69e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	9.6e-06	0.000148	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	9.52e-06	0.000147	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	9.49e-06	0.000146	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	9.39e-06	0.000145	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.19e-06	0.000142	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	9.16e-06	0.000141	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	9.16e-06	0.000141	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.16e-06	0.000141	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	9.13e-06	0.000141	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	9.13e-06	0.000141	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.07e-06	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	9.05e-06	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	9.05e-06	0.00014	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	9.03e-06	0.000139	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	9e-06	0.000139	CbGpPWpGaD
Diphenidol—Methadone—ABCB1—epilepsy syndrome	9e-06	0.00149	CrCbGaD
Diphenidol—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	8.91e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	8.91e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SST—epilepsy syndrome	8.91e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	8.91e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	8.89e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	8.89e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SST—epilepsy syndrome	8.89e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	8.84e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	8.81e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	8.8e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SST—epilepsy syndrome	8.8e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	8.8e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	8.72e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	8.72e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	8.7e-06	0.000134	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	8.69e-06	0.000134	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	8.66e-06	0.000134	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	8.61e-06	0.000133	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	8.57e-06	0.000132	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	8.38e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	8.38e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	8.37e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	8.35e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	8.35e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	8.34e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	8.34e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	8.32e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	8.31e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	8.28e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	8.27e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	8.27e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	8.26e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	8.23e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	8.23e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	8.23e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	8.2e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	8.2e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	8.2e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	8.2e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	8.17e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—HMOX1—epilepsy syndrome	8.13e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	8.12e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	8.12e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	8.09e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	8.03e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CAT—epilepsy syndrome	8.02e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	8e-06	0.000123	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	7.92e-06	0.000122	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ABCB1—epilepsy syndrome	7.8e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	7.79e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	7.77e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	7.69e-06	0.000119	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	7.65e-06	0.000118	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	7.62e-06	0.000118	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	7.6e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	7.58e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	7.55e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	7.5e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	7.47e-06	0.000115	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	7.45e-06	0.000115	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	7.44e-06	0.000115	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	7.41e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	7.37e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	7.34e-06	0.000113	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—GPX1—epilepsy syndrome	7.25e-06	0.000112	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	7.06e-06	0.000109	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	7.04e-06	0.000109	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	6.99e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	6.98e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	6.97e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	6.97e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	6.96e-06	0.000107	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	6.9e-06	0.000107	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	6.89e-06	0.000106	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	6.76e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	6.73e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	6.67e-06	0.000103	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	6.39e-06	9.85e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	6.37e-06	9.82e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AGT—epilepsy syndrome	6.36e-06	9.81e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	6.31e-06	9.73e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—APOE—epilepsy syndrome	6.23e-06	9.61e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	6.21e-06	9.58e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	6.19e-06	9.55e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	6.19e-06	9.55e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	6.18e-06	9.53e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	6.17e-06	9.52e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	6.16e-06	9.5e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.13e-06	9.46e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.11e-06	9.42e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.1e-06	9.41e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.97e-06	9.21e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	5.95e-06	9.18e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	5.9e-06	9.11e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.89e-06	9.09e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	5.89e-06	9.08e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	5.83e-06	8.99e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	5.74e-06	8.86e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	5.73e-06	8.83e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	5.67e-06	8.75e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	5.62e-06	8.67e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	5.6e-06	8.64e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	5.55e-06	8.56e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—POMC—epilepsy syndrome	5.35e-06	8.25e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	5.34e-06	8.24e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	5.33e-06	8.23e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	5.32e-06	8.21e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	5.32e-06	8.2e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	5.27e-06	8.13e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	5.26e-06	8.12e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	5.23e-06	8.06e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	5.21e-06	8.03e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.16e-06	7.96e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	5.12e-06	7.9e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	5.1e-06	7.87e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.05e-06	7.8e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	4.93e-06	7.6e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	4.91e-06	7.58e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	4.91e-06	7.57e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	4.89e-06	7.55e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ALB—epilepsy syndrome	4.88e-06	7.53e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	4.86e-06	7.5e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	4.85e-06	7.47e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.49e-06	6.92e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.47e-06	6.9e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.43e-06	6.84e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	4.39e-06	6.78e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	4.38e-06	6.75e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.34e-06	6.69e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTGS2—epilepsy syndrome	4.27e-06	6.58e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	3.97e-06	6.12e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	3.96e-06	6.1e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	3.92e-06	6.04e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.69e-06	5.68e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.67e-06	5.67e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.64e-06	5.61e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.61e-06	5.57e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.6e-06	5.56e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.57e-06	5.5e-05	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.35e-06	5.17e-05	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.34e-06	5.16e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.32e-06	5.13e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.31e-06	5.11e-05	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.31e-06	5.11e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.28e-06	5.06e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.23e-06	4.98e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	3.22e-06	4.96e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.19e-06	4.92e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.14e-06	4.84e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	3.13e-06	4.83e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.1e-06	4.78e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.05e-06	4.7e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.04e-06	4.68e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.01e-06	4.64e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	2.9e-06	4.47e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	2.89e-06	4.45e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.86e-06	4.41e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.82e-06	4.35e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.81e-06	4.34e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.78e-06	4.29e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.15e-06	3.31e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.8e-06	2.78e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.79e-06	2.77e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.78e-06	2.74e-05	CbGpPWpGaD
